tlooto
Sign up
Open AccessMedicine

Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review

Lijie Xing, Qiang He, Linna Xie, Haibo Wang, Zengjun Li

2021.12.23HAEMATOLOGICA

DOI: 10.3324/haematol.2021.280259

tlooto Summary

Zanubrutinib, rituximab, and lenalidomide induce deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia

Abstract

Not available.

Citation format

XING, Lijie, et al. Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in tp53-mutated b-cell prolymphocytic leukemia: A case report and literature review. HAEMATOLOGICA, 2021, 107: 1226–1228.